CG MedTech

We, CG MedTech, Inc., are committed to promoting enduring vitality by pioneering advancements in regenerative medicine. Our mission is to harness the potential of cutting-edge biomaterial technology to overcome the body's limitations in healing significant injuries. Our expertise lies in scaffold technology is equally robust, featuring medical ceramics, polymers, metals, human tissue processing, and innovative 3D printing techniques. Additionally, we have achieved significant breakthroughs in growth factor technology, including the development of critical proteins like bone morphogenetic protein (rhBMP-2), epidermal growth factor (rhEGF), and transforming growth factor (rhTGF-β3). The synergy of these three elements—cellular, scaffold, and growth factor technologies—is the cornerstone of our future growth. With a comprehensive approach to regenerative medicine, CG MedTech is dedicated to providing innovative solutions that enhance tissue regeneration and improve patient outcomes. Join us as we pave the way towards a future where advanced medical technologies create new possibilities for health and healing.